Clinical trial
Hydroxyapatite Active Pro Healing Clinical Trial Program
NCT00474084 · BioSync Scientific Pvt. Ltd., Industry · Unknown status
Key facts
| NCT number | NCT00474084 |
|---|---|
| Title | Hydroxyapatite Active Pro Healing Clinical Trial Program |
| Official title | First In Man Evaluation of the Vesta™ & VestaCOR™ (Hydroxy-Apetite Coated genX™) Stent for Treatment of de Novo Native Coronary Artery Lesion(s) |
| Acronym | HApFIM |
| Lead sponsor | BioSync Scientific Pvt. Ltd., Industry |
| Collaborators | MIV Therapeutics Inc. Industry Cardialysis BV |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Intravascular Coronary Stent |
| Enrollment | 70 |
| Start date | Jul 1, 2007 |
| First posted | May 16, 2007 |
| Last update posted | May 16, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: